Kees Nooter

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed · 2001 · 752 citations · Full text

Medicine, Oncology, Pharmacology +17

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 415 citations · Full text

Medicine, Molecular Biology, Oncology +11

Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

Alex Sparreboom, Lia van Zuylen, Eric Brouwer et al. · PubMed · 1999 · 340 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Modulation of multidrug-resistant multiple myeloma by cyclosporin

Pieter Sonneveld, Bob Löwenberg, B G M Durie et al. · The Lancet · 1992 · 315 citations

Medicine, Oncology, Pharmacology +12

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Herman Burger, John A. Foekens, Maxime P. Look et al. · PubMed · 2003 · 293 citations · Full text

Medicine, Oncology, Pharmacology +17